Table 1 Selected patient and tumor characteristics
From: Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study
N | 72 | |
Age | ||
Median | 60.1 | |
Range | 29–76 | |
N | % | |
Sex | ||
Male | 40 | 56 |
Female | 32 | 44 |
Concurrent illness | ||
No | 44 | 61 |
Yes | 28 | 39 |
Initial Surgery | ||
No | 1 | 1 |
Yes | 71 | 99 |
Radical Operation | ||
No | 24 | 33 |
Yes | 48 | 67 |
Family history of neoplasia | ||
No | 47 | 65 |
Yes | 22 | 31 |
Unknown | 3 | 4 |
Previous history of cancer | ||
No | 69 | 96 |
Yes | 3 | 4 |
Previous adjuvant treatment | ||
No | 46 | 64 |
Yes | 24 | 33 |
Unknown | 2 | 3 |
Primary site | ||
Cecum | 6 | 8 |
Ascending | 7 | 10 |
Transverse | 5 | 7 |
Descending | 2 | 3 |
Sigmoid | 32 | 44 |
Rectum | 20 | 28 |
Stage | ||
B1 | 1 | 1 |
B2 | 11 | 15 |
C1 | 3 | 4 |
C2 | 16 | 22 |
D | 39 | 54 |
Unknown | 2 | 3 |
Histology grade | ||
I | 5 | 7 |
II | 53 | 74 |
III | 9 | 12 |
Unknown | 5 | 7 |
Metastatic sites of disease | ||
Liver | 54 | 75 |
Abdomen | 8 | 11 |
Pelvis | 3 | 4 |
Lung | 31 | 43 |
Nodes | 9 | 12 |
Bones | 7 | 10 |
Adrenals | 2 | 3 |
Serologic relapse | 4 | 6 |
Other | 4 | 6 |